Education History
| Professional Medical |
Seth G.S. Medical College |
MBBS |
|---|---|---|
| Internship/Residency |
University of Alabama at Birmingham Heersink School of Medicine |
Intern/Resident |
| Fellowship |
University of Texas MD Anderson Cancer Center |
Fellow |
Selected Publications
Journal Article
- Waldschmidt JM, Sotudeh N, Arora S, Vijaykumar T, Anand P, Stuart H, Frede J, Campbell T, Kaiser SM, Zheng X, Munshi NC, Anderson KC, Einsele H, Yee AJ, Knoechel B, Lohr JG, Raje N (2025). Nivolumab to restore T-cell fitness in CAR-T refractory multiple myeloma. Blood advances, 9(5), 1132-1136.
- Senapati J, Loghavi S, Garcia-Manero G, Tang G, Kadia T, Short NJ, Abbas HA, Arani N, DiNardo CD, Borthakur G, Pemmaraju N, Oran B, Shpall E, Popat U, Champlin R, Pierce S, Arora S, Issa G, Yilmaz M, Patel K, Takahashi K, Montalban-Bravo G, Hammond D, Haddad FG, Ravandi F, Kantarjian HM, Daver N (2025). Clinical interrogation of TP53 aberrations and its impact on survival in patients with myeloid neoplasms. Haematologica, 110(6), 1304-1315.
- Fowler ME, Kenzik KM, Al-Obaidi M, Harmon C, Giri S, Arora S, Stephenson C, Khushman M, Outlaw D, Bhatia S, Williams G (2023). Rural-urban disparities in mortality and geriatric assessment among older adults with cancer: The cancer & aging resilience evaluation (CARE) registry. Journal of geriatric oncology, 14(4), 101505.
- Arora S, Zainaldin C, Bathini S, Gupta U, Worth S, Bachiashvili K, Bhatia R, Godby K, Jamy O, Rangaraju S, Diamond B, Oliver JD, Salzman D, Di Stasi A, Vachhani (2022). Tumor lysis syndrome and infectious complications during treatment with venetoclax combined with azacitidine or decitabine in patients with acute myeloid leukemia. Leukemia research, 117, 106844.
- Arora S, Fowler ME, Harmon C, Al-Obaidi M, Outlaw D, Hollis R, Gbolahan O, Khushman M, Giri S, Williams G (2022). Differences in Pretreatment Frailty Across Gastrointestinal Cancers in Older Adults: Results From the Cancer and Aging Resilience Evaluation Registry. JCO oncology practice, 18(11), e1796-e1806.
- Zainaldin C, Arora S, Bathini S, Gupta U, Pandya V, Bae S, Worth S, Bachiashvili K, Bhatia R, Godby K, Jamy O, Rangaraju S, Diamond B, Oliver JD, Salzman D, Di Stasi A, Vachhani (2022). Dismal survival outcomes of patients with acute myeloid leukemia after failure of venetoclax with hypomethylating agents. Leukemia & lymphoma, 63(13), 3245-3248.
- Gokarn A, Toshniwal A, Pathak A, Arora S, Bonda A, Punatar S, Nayak L, Dwivedi P, Bhat V, Biswas S, Kelkar R, Kannan S, Khattry (2019). Use of Leflunomide for Treatment of Cytomegalovirus Infection in Recipients of Allogeneic Stem Cell Transplant. Biology of blood and marrow transplantation, 25(9), 1832-1836.
Review
- Arora S, Vachhani P, Bose (2024). Investigational drugs in early phase trials for myelofibrosis. Expert opinion on investigational drugs, 33(12), 1231-1244.
- Arora S, Asawa P, Ramakrishnan A, Bachier C, Majhail N (2022). Adoptive Cellular Therapy in Acute Myeloid Leukemia: Current Scope and Challenges. Hematology/oncology and stem cell therapy, 15(3), 159-167.
- Arora S, Asawa P, Kataria N, Hendriks LEL, Desai A (2022). Management of Non-Small Cell Lung Cancer: Updates from the European Lung Cancer Congress 2022. Cancer investigation, 40(7), 577-589.
Letter
- Jamy O, Arora S, Meredith R, Salzman D, Di Stasi A, Minagawa K, Mineishi S, Saad (2022). Phase II study of myeloablative allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia in adults using fludarabine and total body irradiation 12¿Gy. Bone marrow transplantation, 57(10), 1597-1599.
- Tiwari NR, Arora S, Tolat AG, Shaheen SP 2nd, Sharma V (2022). TTP or complement-mediated TMA or both? A rare diagnosis and report of a novel plasminogen gene variant. Annals of hematology, 101(3), 725-727.
- Arora S, Vachhani P, Bachiashvili K, Jamy (2021). Venetoclax with chemotherapy in relapse/refractory early T-cell precursor acute lymphoblastic leukemia. Leukemia & lymphoma, 62(9), 2292-2294.